Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study
Authors
Keywords
-
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-13
DOI
10.1007/s40618-020-01478-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study
- (2019) Sema Ciftci Dogansen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review
- (2019) Emilia M. Gatto et al. Frontiers in Neurology
- Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors
- (2019) Sunita M C De Sousa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sex differences in impulsive and compulsive behaviors: a focus on drug addiction
- (2016) Liana Fattore et al. ADDICTION BIOLOGY
- Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder
- (2014) M. L. Fantini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study
- (2013) Irina Bancos et al. CLINICAL ENDOCRINOLOGY
- Impulse Control Disorder in a Patient on Long-Term Treatment With Bromocriptine for a Macroprolactinoma
- (2013) Sravan Kumar Thondam et al. CLINICAL NEUROPHARMACOLOGY
- The “Test Your Memory” test performs better than the MMSE in a population without known cognitive dysfunction
- (2013) Paula S. Koekkoek et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
- (2013) Maya Barake et al. Pituitary
- Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers
- (2012) Amira K. Brown et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Distinct Dopaminergic Personality Patterns in Patients with Prolactinomas: A Comparison with Nonfunctioning Pituitary Adenoma Patients and Age- and Gender-Matched Controls
- (2012) A.P. Athanasoulia et al. NEUROENDOCRINOLOGY
- Dopamine Agonist-Induced Impulse Control Disorders in a Patient with Prolactinoma
- (2012) Santiago Almanzar et al. PSYCHOSOMATICS
- Impulse Control Disorders Associated With Dopaminergic Medication in Patients With Pituitary Adenomas
- (2011) Jana Martinkova et al. CLINICAL NEUROPHARMACOLOGY
- Dopaminergika-induziertes Pathologisches Glücksspiel
- (2011) M. Gahr et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease
- (2011) J. Eric Ahlskog PHYSIOLOGY & BEHAVIOR
- Impulse Control Disorders: Updated Review of Clinical Characteristics and Pharmacological Management
- (2011) Liana Schreiber et al. Frontiers in Psychiatry
- Impulse Control Disorders in Parkinson Disease
- (2010) Daniel Weintraub et al. ARCHIVES OF NEUROLOGY
- Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease
- (2009) Daniel Weintraub et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now